Delivery Order SPE2DB24D3013-SPE2DB25FFNLW
Award Date 7/21/25
Potential Completion Date 7/22/25
Potential Value $2.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GEMTESA 75 MG TABLET 30S, with a ceiling value of $1,866.94 and a completion date of June 18, 2025. The contract is not set-aside and is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that Amerisourcebergen holds with the DLA Troop...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of GEMTESA 75 MG TABLET 90S. The delivery order has a ceiling value of $6,121.76 and is a firm fixed-price contract. It does not have a set-aside designation, indicating open competition. The ultimate completion date for this delivery order is May 19, 2025. AmerisourceBergen Drug Corp is a prime contractor that holds a larger $999,999,999.00...
- This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,982.14, is for the delivery of GEMTESA 75 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of July 2, 2025. This delivery order is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA, valued...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of GEMTESA 75 MG TABLET 30S, a prescription medication, with a ceiling value of $3,088.16 and a performance period ending on May 22, 2025. The contract is a Firm Fixed Price (FFP) delivery order, without a set-aside designation, indicating open competition. Amerisourcebergen...
- This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GEMTESA 75 MG TABLET 90S, a pharmaceutical product, with a total ceiling value of $4,562.81. The contract has an ultimate completion date of May 19, 2025. This order is not set aside and is awarded as part of a larger Indefinite Delivery Contract (IDC) worth...
- This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of GEMTESA 75 MG TABLET 30S. The contract has a ceiling value of $1,703.29 and will run through September 24, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the government to...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of GEMTESA 75 MG TABLET 30S. The contract has a ceiling value of $2,197.65 and an ultimate completion date of June 27, 2024. It is a firm fixed-price contract, with no set-aside designation. Amerisourcebergen Drug Corp's Corporate Office division will be responsible for fulfilling this order, which is likely part of the company's broader...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $7,986.85 firm fixed price contract is for the supply of GEMTESA 75 MG TABLET 90S, a prescription medication. The award does not have a set-aside designation. The delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, that enables the government to efficiently...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of GEMTESA 75 MG TABLET 90S. The delivery order has a ceiling value of $38,642.13 and a period of performance through March 18, 2024. Amerisourcebergen Drug Corp is the prime contractor on this award, which is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of GEMTESA 75 MG TABLET 90S. The award, valued at $4,780.60, has a firm fixed price and is set to be completed by September 23, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued up to $999,999,999, for the provision of a...